US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer
Daiichi Sankyo
Preeti Narayan; Asma Dilawari; Christy Osgood; Zhou Feng; Erik Bloomquist; William F Pierce; Samina Jafri; Shyam Kalavar; Marina Kondratovich; Prakash Jha; Soma Ghosh; Shenghui Tang; Richard Pazdur; Julia A Beaver; Laleh Amiri-Kordestani